By Kimberly Chin

Stryker Corp. said profit rose in the third quarter as sales picked up due to an increase in unit volume although the company warned that the ongoing pandemic can still weigh on deferrable medical procedures.

The medical-technology company's profit was $621 million, or $1.63 a share, up from $461 million, or $1.23 a share, a year earlier. Adjusted profit was $2.14 a share. Analysts polled by FactSet were expecting adjusted earnings of $1.41 a share.

Net sales rose to $3.74 billion from $3.59 billion in the comparable period a year earlier, ahead of analysts' expectations of $3.41 billion.

The Kalamazoo, Mich., company's total operating expenses declined by 5.9% to $1.6 billion.

The measures to contain the spread of the Covid-19 pandemic has led to the postponement of many deferrable medical procedures, which will continue to have a negative effect on the company's financial results, Stryker said.

Write to Kimberly Chin at kimberly.chin@wsj.com

(END) Dow Jones Newswires

October 29, 2020 16:41 ET (20:41 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Stryker (NYSE:SYK)
Historical Stock Chart
From Nov 2020 to Dec 2020 Click Here for more Stryker Charts.
Stryker (NYSE:SYK)
Historical Stock Chart
From Dec 2019 to Dec 2020 Click Here for more Stryker Charts.